Candel Therapeutics (CADL) Shares Issued (2020 - 2025)
Candel Therapeutics (CADL) posted Shares Issued of $4.1 million for Q4 2025, up 4.3% sequentially from $3.9 million in Q3 2025, and down 8.62% YoY from $4.5 million in Q4 2024.
Candel Therapeutics (CADL) Shares Issued (2020 - 2025) Analysis & Trends
Candel Therapeutics has reported Shares Issued for 6 years, with the latest figure at $4.1 million in Q4 2025.
- Quarterly Shares Issued fell 8.62% year-over-year to $4.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $4.1 million (down 8.62% YoY) and the FY2025 annual result came in at $4.1 million, down 8.62% from the prior year.
- Shares Issued climbed to $4.1 million in Q4 2025 per CADL's latest filing, from $3.9 million in the prior quarter.
- Over five years, Shares Issued peaked at $6.2 million in Q3 2022 and troughed at $1.1 million in Q2 2021.
- A 5-year average of $4.0 million and a median of $4.1 million in 2025 frame the typical range for Shares Issued.
- The sharpest annual moves came in 2022 and 2023: Shares Issued surged 437.37% in 2022, then tumbled 71.67% in 2023.
- Over 5 years, Shares Issued stood at $4.8 million in 2021, then grew by 18.02% to $5.6 million in 2022, then gained by 0.38% to $5.7 million in 2023, then dropped by 20.83% to $4.5 million in 2024, then decreased by 8.62% to $4.1 million in 2025.
- According to Business Quant data, Shares Issued over the past three periods registered $4.1 million, $3.9 million, and $2.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 18.36 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Candel Therapeutics | 643.41 Mn | 643.41 Mn | - | 4.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 4.10 Mn |
| Dec 31, 2025 | 4.10 Mn |
| Sep 30, 2025 | 3.93 Mn |
| Sep 30, 2025 | 3.93 Mn |
| Jun 30, 2025 | 2.02 Mn |
| Jun 30, 2025 | 2.02 Mn |
| Mar 31, 2025 | 5.92 Mn |
| Mar 31, 2025 | 5.92 Mn |
| Dec 31, 2024 | 4.49 Mn |
| Dec 31, 2024 | 4.49 Mn |
| Sep 30, 2024 | 2.01 Mn |
| Sep 30, 2024 | 2.01 Mn |
| Jun 30, 2024 | 1.94 Mn |
| Jun 30, 2024 | 1.94 Mn |
| Mar 31, 2024 | 3.50 Mn |
| Mar 31, 2024 | 3.50 Mn |
| Dec 31, 2023 | 5.67 Mn |
| Dec 31, 2023 | 5.67 Mn |
| Sep 30, 2023 | 6.06 Mn |
| Sep 30, 2023 | 6.06 Mn |